{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:49:09Z","timestamp":1762458549894},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1007\/s11914-005-0025-7","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T22:20:14Z","timestamp":1180131614000},"page":"30-34","source":"Crossref","is-referenced-by-count":24,"title":["Strontium ranelate: A new treatment for postmenopausal osteoporosis with a dual mode of action"],"prefix":"10.1007","volume":"3","author":[{"given":"Jean-Yves","family":"Reginster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Sarlet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Lejeune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Leonori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"25_CR1","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/8756-3282(96)00080-4","volume":"18","author":"E Canalis","year":"1996","unstructured":"Canalis E, Hott M, Deloffre P, et al.: The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro. Bone 1996, 18:517\u2013523.","journal-title":"Bone"},{"key":"25_CR2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s002230010055","volume":"69","author":"PJ Marie","year":"2001","unstructured":"Marie PJ, Ammann P, Boivin G, Rey C: Mechanisms of action and therapeutic potential of strontium in bone. Calcif Tissue Int 2001, 69:121\u2013129.","journal-title":"Calcif Tissue Int"},{"key":"25_CR3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF02383408","volume":"12","author":"T Izumisawa","year":"1994","unstructured":"Izumisawa T, Morohashi T, Amano H, Yamada S: The effect of stable strontium on calcium metabolism: II. Effect of 1-hydroxyvitamin D3 in strontium-fed rats and inhibitory effect of strontium on bone resorption in vitro. J Bone Miner Metab 1994, 12:43\u201349.","journal-title":"J Bone Miner Metab"},{"key":"25_CR4","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1359\/jbmr.2003.18.6.1082","volume":"18","author":"N Takahashi","year":"2003","unstructured":"Takahashi N, Sasaki T, Tsouderos Y, Suda T: S12911-2 inhibits osteoclastic bone resorption in vitro. J Bone Miner Res 2003, 18:1082\u20131087.","journal-title":"J Bone Miner Res"},{"key":"25_CR5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0014-2999(02)02040-X","volume":"450","author":"R Baron","year":"2002","unstructured":"Baron R, Tsouderos Y: In vitro effects of S12911-2 on osteo-clast function and bone marrow macrophage differentiation. Eur J Pharmacol 2002, 450:11\u201317.","journal-title":"Eur J Pharmacol"},{"key":"25_CR6","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S8756-3282(01)00484-7","volume":"29","author":"J Buehler","year":"2001","unstructured":"Buehler J, Chappuis P, Saffar JL, et al.: Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys (Macaca fascicularis). Bone 2001, 29:176\u2013179.","journal-title":"Bone"},{"key":"25_CR7","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/jbmr.5650110915","volume":"11","author":"G Boivin","year":"1996","unstructured":"Boivin G, Deloffre P, Perrat B, et al.: Strontium distribution and interactions with bone mineral density in monkey iliac bone after strontium salt (S12911) administration. J Bone Miner Res 1996, 11:1302\u20131311.","journal-title":"J Bone Miner Res"},{"key":"25_CR8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1254\/jjp.68.153","volume":"68","author":"T Morohashi","year":"1995","unstructured":"Morohashi T, Sano T, Harai K, Yamada S: Effects of strontium on calcium metabolism in rats II. Strontium prevents the increased rate of bone turnover in ovariectomized rats. Jpn J Pharmacol 1995, 68:153\u2013159.","journal-title":"Jpn J Pharmacol"},{"key":"25_CR9","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/jbmr.5650080512","volume":"8","author":"PJ Marie","year":"1993","unstructured":"Marie PJ, Hott M, Modrowski D, et al.: An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintining bone formation in estrogen-deficient rats. J Bone Miner Res 1993, 8:607\u2013615.","journal-title":"J Bone Miner Res"},{"key":"25_CR10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S8756-3282(03)00115-7","volume":"33","author":"M Hott","year":"2003","unstructured":"Hott M, Deloffre P, Tsouderos Y, Marie PJ: S12911-2 reduces bone loss induced by short-term immobilization in rats. Bone 2003, 33:115\u2013123.","journal-title":"Bone"},{"key":"25_CR11","first-page":"2060","volume":"87","author":"PJ Meunier","year":"2002","unstructured":"Meunier PJ, Slosman D, Delmas P, et al.: Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis: a 2-year randomized placebo controlled trial. J Clin Endocrinol Metab 2002, 87:2060\u20132066. The first trial showing an effect on strontium ranelate on BMD and biochemical markers of bone turnover in postmenopausal women.","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"25_CR12","first-page":"305","volume":"15","author":"G Boivin","year":"2000","unstructured":"Boivin G, Foos E, Tupinon-Mathieu I, Meunier PJ: Strontium deposition in bone is dose dependent and does not alter the degree of mineralization of bone in osteoporotic patients treated with strontium ranelate. J Bone Miner Res 2000, 15(Suppl 1):305.","journal-title":"J Bone Miner Res"},{"issue":"Suppl 1","key":"25_CR13","first-page":"S24","volume":"13","author":"JY Reginster","year":"2002","unstructured":"Reginster JY, Diez-Perez A, Ortolani S, et al.: Calcium-vitamin D supplementation in clinical trials of osteoporosis should be titrated on the basis of pre-study assessments. Osteoporos Int 2002, 13(Suppl 1):S24.","journal-title":"Osteoporos Int"},{"issue":"Suppl 1","key":"25_CR14","first-page":"S30","volume":"13","author":"JY Reginster","year":"2002","unstructured":"Reginster JY, Spector T, Badurski J, et al.: A short-term run-in study can significantly contribute to increasing the quality of long-term osteoporosis trials. The strontium ranelate Phase III program. Osteoporos Int 2002, 13(Suppl 1):S30.","journal-title":"Osteoporos Int"},{"key":"25_CR15","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","volume":"8","author":"HK Genant","year":"1993","unstructured":"Genant HK, Wu CY, Van Kuijk C, Newit MC: Vertebral semi quantitative assessment using a semi-quantitative technique. J Bone Miner Res 1993, 8:1137\u20131148.","journal-title":"J Bone Miner Res"},{"issue":"Suppl 1","key":"25_CR16","first-page":"O45","volume":"13","author":"PJ Meunier","year":"2002","unstructured":"Meunier PJ, Roux Ortolani S, et al.: Strontium ranelate reduces the vertebral fracture risk in women with postmenopausal osteoporosis. Osteoporos Int 2002, 13(Suppl 1):O45.","journal-title":"Osteoporos Int"},{"key":"25_CR17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa022436","volume":"350","author":"PJ Meunier","year":"2004","unstructured":"Meunier PJ, Roux Seeman E, et al.: The effect of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 2004, 350:459\u2013468. A prospective double-blind randomized study demonstrating the antifracture efficacy of strontium ranelate, in spinal osteoporosis in postmenopausal women.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"25_CR18","first-page":"OC39","volume":"15","author":"R Rizzoli","year":"2004","unstructured":"Rizzoli R, Reginster JY, Diaz-Curiel M, et al.: Patients at high risk of hip fracture benefit from treatment with strontium ranelate. Osteoporos Int 2004, 15(Suppl 1):OC39.","journal-title":"Osteoporos Int"},{"issue":"Suppl 1","key":"25_CR19","first-page":"P151","volume":"74","author":"JY Reginster","year":"2004","unstructured":"Reginster JY, Rizzoli R, Balogh A, et al.: Strontium ranelate reduces the risk of vertebral fractures in osteoporotic post menopausal women without prevalent vertebral fracture. Calcif Tissue Int 2004, 74(Suppl 1):P151.","journal-title":"Calcif Tissue Int"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-005-0025-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11914-005-0025-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-005-0025-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:31:52Z","timestamp":1559435512000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11914-005-0025-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["25"],"URL":"https:\/\/doi.org\/10.1007\/s11914-005-0025-7","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}